+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Neurofibromatosis Type 2 - Pipeline Insight, 2025 - Product Thumbnail Image

Neurofibromatosis Type 2 - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Neuropathic Pain - Pipeline Insight, 2025 - Product Thumbnail Image

Neuropathic Pain - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Niemann-Pick Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Niemann-Pick Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Night Vision Disturbances - Pipeline Insight, 2025 - Product Thumbnail Image

Night Vision Disturbances - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Recurrent Pericarditis - Pipeline Insight, 2025 - Product Thumbnail Image

Recurrent Pericarditis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cardiotoxicity - Pipeline Insight, 2025 - Product Thumbnail Image

Cardiotoxicity - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Central Retinal Vein Occlusion - Pipeline Insight, 2025 - Product Thumbnail Image

Central Retinal Vein Occlusion - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Chronic Neuropathic Pain - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Neuropathic Pain - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Aneurysmal Subarachnoid Hemorrhage- Pipeline Insight, 2025 - Product Thumbnail Image

Aneurysmal Subarachnoid Hemorrhage- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Angioedema- Pipeline Insight, 2025 - Product Thumbnail Image

Angioedema- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Antibody-Mediated Graft Rejection - Pipeline Insight, 2025 - Product Thumbnail Image

Antibody-Mediated Graft Rejection - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Anti-hypertension - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-hypertension - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Antiphospholipid Syndrome (APS) - Pipeline Insight, 2025 - Product Thumbnail Image

Antiphospholipid Syndrome (APS) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Asthma - Pipeline Insight, 2025 - Product Thumbnail Image

Asthma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Ataxia Telangiectasia- Pipeline Insight, 2025 - Product Thumbnail Image

Ataxia Telangiectasia- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Atopic Dermatitis - Pipeline Insight, 2025 - Product Thumbnail Image

Atopic Dermatitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 280 Pages
  • Global
From
Attention Deficit Hyperactivity Disorder - Pipeline Insight, 2025 - Product Thumbnail Image

Attention Deficit Hyperactivity Disorder - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Atypical Hemolytic Uremic Syndrome (aHUS) - Pipeline Insight, 2025 - Product Thumbnail Image

Atypical Hemolytic Uremic Syndrome (aHUS) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Autism Spectrum Disorder (ASD) - Pipeline Insight, 2025 - Product Thumbnail Image

Autism Spectrum Disorder (ASD) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Autoimmune Pulmonary Alveolar Proteinosis (aPAP) - Pipeline Insight, 2025 - Product Thumbnail Image

Autoimmune Pulmonary Alveolar Proteinosis (aPAP) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more